Association between Atrial Fibrillation and Three-Year Mortality in Nondiabetic Patients with Acute First-Ever

Chun-Hsueh Chu1, Wei-Chieh Weng1, Feng-Chieh Su1

  • 1Department of Neurology, Chang-Gung Memorial Hospital, Keelung, Taiwan; Department of Medicine, College of Medicine, Chang Gung University, Tao-Yuan, Taiwan.

Insights

Atrial fibrillation (AF) increases 3-year mortality risk in nondiabetic patients after ischemic stroke. Early cardiac evaluation and treatment are crucial for managing stroke outcomes in these patients.

Area of Science:

  • Cardiology
  • Neurology
  • Public Health

Background:

  • Diabetes mellitus (DM) is a known risk factor for atrial fibrillation (AF) and stroke mortality.
  • The impact of AF on long-term outcomes in ischemic stroke patients requires further clarification, especially independent of DM.
  • This study investigates AF's influence on 3-year outcomes in nondiabetic patients with acute first-ever ischemic stroke.

Purpose of the Study:

  • To determine the independent effect of atrial fibrillation (AF) on the 3-year outcomes of nondiabetic patients experiencing an acute first-ever ischemic stroke.
  • To assess the association between AF and mortality, functional status, and healthcare utilization in this specific patient cohort.
  • To provide evidence supporting targeted cardiac evaluation and management strategies for stroke patients with AF.

Main Methods:

  • A cohort of 574 nondiabetic patients with acute first-ever ischemic stroke was followed for 3 years.
  • Patients were categorized into two groups: those with and without diagnosed AF.
  • Clinical data, stroke risk factors, laboratory results, comorbidities, and 3-year outcomes were systematically recorded and analyzed.

Main Results:

  • Atrial fibrillation (AF) was diagnosed in 18.6% of the study population (107 patients).
  • Patients with AF were older and had a higher incidence of total anterior circulation syndrome.
  • AF was significantly associated with longer hospital stays, increased dependency post-discharge, and a 1.98-fold increased risk of 3-year all-cause mortality (P=.022).

Conclusions:

  • Atrial fibrillation (AF) is an independent predictor of increased 3-year mortality in nondiabetic patients following an acute ischemic stroke.
  • These findings underscore the critical need for thorough cardiac assessment and timely intervention in stroke patients diagnosed with AF.
  • Effective management of AF in stroke survivors is essential for improving long-term prognosis and reducing mortality.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
378
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
553
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.4K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
564
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
516